N-((2S,6R,18S,32aR)-6-(tert-butyl)-2-hydroxy-27-(4-methylthiazol-5-yl)-5,8,32-trioxo-1,2,3,5,6,7,8,9,11,12,14,15,17,18,20,21,23,24,30,31,32,32a-docosahydrobenzo[a₁]pyrrolo[1,2-v][1,4,7,10,13,16,19,22,25]hexaoxatriazacyclooctacosin-18-yl)-2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetamide

ID: ALA5290134

Chembl Id: CHEMBL5290134

Max Phase: Preclinical

Molecular Formula: C53H66ClN9O11S2

Molecular Weight: 1104.75

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc2c(c1)OCCOCCO[C@H](NC(=O)C[C@@H]1N=C(c3ccc(Cl)cc3)c3c(sc(C)c3C)-n3c(C)nnc31)COCCOCCOCC(=O)N[C@H](C(C)(C)C)C(=O)N1C[C@@H](O)C[C@@H]1C(=O)NC2

Standard InChI:  InChI=1S/C53H66ClN9O11S2/c1-30-32(3)76-52-45(30)46(34-10-12-37(54)13-11-34)57-39(49-61-60-33(4)63(49)52)24-42(65)58-44-28-72-17-15-69-14-16-71-27-43(66)59-48(53(5,6)7)51(68)62-26-38(64)23-40(62)50(67)55-25-36-9-8-35(47-31(2)56-29-75-47)22-41(36)73-20-18-70-19-21-74-44/h8-13,22,29,38-40,44,48,64H,14-21,23-28H2,1-7H3,(H,55,67)(H,58,65)(H,59,66)/t38-,39-,40+,44-,48-/m0/s1

Standard InChI Key:  XWYAQFRIAAYGOB-XIDYEGKZSA-N

Alternative Forms

1. Parent:

   

   ALA5290134

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1104.75

Molecular Weight (Monoisotopic): 1103.4012

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Li D, Yu D, Li Y, Yang R..  (2022)  A bibliometric analysis of PROTAC from 2001 to 2021.,  244  [PMID:36274273] [10.1016/j.ejmech.2022.114838]

Source

Source(1):

• Scientific Literature